Multidimensional insights into antifungal resistance and pathogenesis of Candida parapsilosis:Clinical outbreaks, molecular mechanisms, and host-pathogen interactions
Year: 2026
Type: other
Abstract: Global outbreaks caused by fluconazole-resistant (FLCR) C. parapsilosis isolates impose an imminent threat to public health due to being associated with higher mortality rates and outbreak persistence despite the application of strict infection control strategies. Therefore, deeper clinical and microbiological attributes associated with such outbreaks are warranted to effectively combat this persistent global threat. Through acquisition of clinical C. parapsilosis isolates collected from different countries and leveraging functional genetic analysis and extensive models, this thesis aims at dissection of molecular pathways underpinning antifungal resistance/tolerance and virulence. The expert review outlines the current understanding regarding clinical, microbiological, and immunological attributes associated with FLCR C. parapsilosis outbreaks. Whereas the other chapters utilize genotyping tools, functional genetic studies and gene expression analysis to understand the molecular mechanisms underpinning antifungal resistance and tolerance. Through combination of whole-genome sequencing (WGS) and diverse in-vitro, ex-vivo, and in-vivo analysis, we noted that multidrug-resistant (MDR) C. parapsilosis isolates causing outbreaks in Turkey exhibit robust fitness in various organs of immunocompetent mice, which highlights the recent outbreaks caused by MDR C. parapsilosis isolates as the next clinical threat. Finally, using state-of-the-art cell wall analysis, WGS, extensive transcriptomics, phenotypic, ex-vivo, and in-vivo systemic infection mouse models, we identify a cell wall remodeling underlying tolerance to an antifungal drug and to critical components of innate immune cells. Collectively, this thesis uncovers novel microbiological attributes underlying antifungal resistance/tolerance and virulence and highlights unmet need for future research to minimize the imminent threat posed by C. parapsilosis in clinical settings.
Author: Daneshnia, F.
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Gordon and Betty Moore Foundation, Amgen, Pfizer, Gilead Sciences, Memorial Sloan-Kettering Cancer Center, “la Caixa” Foundation, European Commission, Science Foundation Ireland, Fundação de Amparo à Pesquisa do Estado de São Paulo, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Ministerio de Ciencia e Innovación, Astellas Pharma, Chinese Academy of Engineering, National Institutes of Health, Fundação para a Ciência e a Tecnologia, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, European Regional Development Fund, National Key Research and Development Program of China, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Awards: G1266426425, G1336669551, G1971349640, G3989255109, G4305859373, G434337789, G5118344331, G517780428, circ_0091746以内源性竞争RNA方式结合miR-6848-5p在巨噬细胞抗新生隐球菌感染M1/M2极化中的作用及调控机制, G5506218483, Effect of genome diversity on antifungal drug resistance in the human pathogen Candida parapsilosis., Multidisciplinary and international network to characterize microbiological aspects and natural history of invasive fungal infections due Candida spp, G6070875828, Deciphering the Origin of the Eukaryotic Cell, G7054627648, G7179701415, G8592501101, G8681152003, Critical Factors Influencing Echinocandin Resistance in Candida glabrata
OpenAlex ID: W7135938396
